Date added: 2022-01-28
JPND (EU Joint Programme - Neurodegenerative Disease Research)
Neurodegenerative diseases are debilitating and largely untreatable conditions that are strongly linked with age. Worldwide, there are estimated to be 50 million people suffering from Alzheimer’s disease and related disorders, the most common class of neurodegenerative diseases. This figure is expected to double every 20 years as the population ages. The total direct and informal care costs of Alzheimer’s, Parkinson’s and related disorders are expected to surpass €350 billion per year across the European Union and about US$ one trillion worldwide. Existing treatments for neurodegenerative diseases are limited in effect and mainly address the symptoms rather than the cause or the progressive course. With this in mind, JPND has identified a pressing need for investment aimed at enabling research projects on understanding the mechanisms of non-pharmacological interventions.
This transnational call invites proposals for ambitious, innovative, multinational and multidisciplinary collaborative research projects aimed at improving the understanding of the mechanisms and biological substrates that underlie non-pharmacological interventions, in order to tailor a holistic personalised treatment approach.
The following countries participate in the competition: Australia, Belgium, Czech Republic, Denmark, Finland, France, Spain, Netherlands, Canada, Luxembourg, Latvia, Germany, Norway, Poland, Slovakia, Switzerland, Turkey, Hungary, Italy.
Deadlines
Pre-proposals must be submitted no later than 12:00h C.E.T. on March 1, 2022, via the electronic submission tool.
Full proposals must be submitted no later than 12:00h C.E.S.T on June 28, 2022, via the electronic submission tool.
More information
Please check here for detailed information. The official website of JPND is also available here.
-
2023-05-15
Scholarships to the USA – apply until May 26
-
2023-05-10
The Bekker NAWA Programme
-
2023-05-09
Poland My First Choice NAWA Programme